India’s fourth largest Pharma Company Piramal Healthcare Limited (PHL) is ideally poised to give good performance in the coming quarters. Unlike Divis and Glenmark, Piramal is reasonable valued and like Sun Pharma, it is going to post good results in this quarter. PHL is improving its core generic business while betting big on Contract Research and Manufacturing Services (CRAMS).
comments Discuss   addto Add this link to...  recommend Tell a friend   report Bury






Related Links Comments Who Voted